UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma

UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma

Abstract Background To discover biomarker panels that could distinguish cancers (BC and RCC) from healthy controls (HCs) and bladder cancers (BC) from renal cell carcinoma (RCC), regardless of whether the patients have haematuria. In addition, we also explored the altered metabolomic pathways of BC...

Full description

Bibliographic Details
Main Authors: Zhan Wang, Xiaoyan Liu, Xiang Liu, Haidan Sun, Zhengguang Guo, Guoyang Zheng, Yushi Zhang, Wei Sun
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Cancer
Subjects:
Metabolomics
UPLC-MS
Biomarkers
Bladder cancer
Renal cell carcinoma
Online Access:https://doi.org/10.1186/s12885-019-6354-1

Internet

https://doi.org/10.1186/s12885-019-6354-1

Similar Items